Advertisement

Clinical characteristics of Japanese diabetic patients with critical limb ischemia presenting Fontaine stage IV

  • Mitsuyoshi Takahara
  • Osamu Iida
  • Yukihiro Fujita
  • Masakazu Haneda
Short Communication
  • 4 Downloads

Abstract

The aim of the current study was to reveal the clinical characteristics of Japanese diabetic patients with critical limb ischemia (CLI) presenting ischemic unhealed ulcer/gangrene (Fontaine stage IV) in the real-world settings. The current retrospective cross-sectional study included consecutive 282 Japanese diabetic patients who underwent endovascular therapy for CLI presenting Fontaine stage IV. The prevalence of diabetes-related complications was estimated adopting multiple imputation (50 times). The patients were aged 70 ± 10 years. Median duration of diabetes was 21 (interquartile range 12–31) years. The prevalence of proliferative diabetic retinopathy, end-stage renal disease on regular dialysis, stroke, coronary artery disease, and chronic heart failure was estimated at 48% (95% confidence interval 39–56%), 52% (46–58%), 34% (28–39%), 48% (42–54%), and 35% (29–41%), respectively. The prevalence of stroke, coronary artery disease, and chronic heart failure was not significantly associated with the duration of diabetes (all p > 0.05). On the other hand, the prevalence of proliferative diabetic retinopathy and end-stage renal disease on regular dialysis was significantly positively associated with the duration of diabetes (both p < 0.05). However, these prevalences reached as high as ~ 30% even in patients with duration of diabetes < 10 years. In conclusion, the advanced stage of diabetes-related complications was prevalent in patients with CLI presenting Fontaine stage IV.

Keywords

Critical limb ischemia Fontaine stage IV Diabetes-related complication Prevalence 

Notes

Acknowledgements

This study was supported by a Grant-in-Aid (No. 201709007A and No. 201608012A) for Scientific Research from the Ministry of Health, Labour and Welfare of Japan.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflicts of interests associated with this manuscript.

Human rights statement

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later revision.

References

  1. 1.
    Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33(Suppl 1):S1–75.CrossRefPubMedGoogle Scholar
  2. 2.
    Iida O, Takahara M, Soga Y, Kodama A, Terashi H, Azuma N. Three-year outcomes of surgical versus endovascular revascularization for critical limb ischemia: the SPINACH study (Surgical Reconstruction Versus Peripheral Intervention in Patients With Critical Limb Ischemia). Circ Cardiovasc Interv. 2017;10:e005531.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Haneda M, Noda M, Origasa H, Noto H, Yabe D, Fujita Y, et al. Japanese clinical practice guideline for diabetes 2016. Diabetol Int. 2018;9:1–45.CrossRefGoogle Scholar
  4. 4.
    Yokoyama H, Kawai K, Kobayashi M. Microalbuminuria is common in Japanese type 2 diabetic patients: a nationwide survey from the Japan Diabetes Clinical Data Management Study Group (JDDM 10). Diabetes Care. 2007;30:989–92.CrossRefPubMedGoogle Scholar
  5. 5.
    Hayashino Y, Izumi K, Okamura S, Nishimura R, Origasa H, Tajima N. Duration of diabetes and types of diabetes therapy in Japanese patients with type 2 diabetes: the Japan Diabetes Complication and its Prevention prospective study 3 (JDCP study 3). J Diabetes Investig. 2017;8:243–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Sone H, Katagiri A, Ishibashi S, Abe R, Saito Y, Murase T, et al. Effects of lifestyle modifications on patients with type 2 diabetes: the Japan Diabetes Complications Study (JDCS) study design, baseline analysis and 3 year-interim report. Horm Metab Res. 2002;34:509–15.CrossRefPubMedGoogle Scholar
  7. 7.
    Ueki K, Sasako T, Kato M, Okazaki Y, Okahata S, Katsuyama H, et al. Design of and rationale for the Japan Diabetes Optimal Integrated Treatment study for three major risk factors of cardiovascular diseases (J-DOIT3): a multicenter, open-label, randomized, parallel-group trial. BMJ Open Diabetes Res Care. 2016;4:e000123.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Uccioli L, Gandini R, Giurato L, Fabiano S, Pampana E, Spallone V, et al. Long-term outcomes of diabetic patients with critical limb ischemia followed in a tertiary referral diabetic foot clinic. Diabetes Care. 2010;33:977–82.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Lejay A, Georg Y, Tartaglia E, Gaertner S, Geny B, Thaveau F, et al. Long-term outcomes of direct and indirect below-the-knee open revascularization based on the angiosome concept in diabetic patients with critical limb ischemia. Ann Vasc Surg. 2014;28:983–9.CrossRefPubMedGoogle Scholar
  10. 10.
    Freisinger E, Malyar NM, Reinecke H, Lawall H. Impact of diabetes on outcome in critical limb ischemia with tissue loss: a large-scaled routine data analysis. Cardiovasc Diabetol. 2017;16:41.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Noronen K, Saarinen E, Alback A, Venermo M. Analysis of the elective treatment process for critical limb ischaemia with tissue loss: diabetic patients require rapid revascularisation. Eur J Vasc Endovasc Surg. 2017;53:206–13.CrossRefPubMedGoogle Scholar
  12. 12.
    Meloni M, Izzo V, Giurato L, Del Giudice C, Da Ros V, Cervelli V, et al. Recurrence of critical limb ischemia after endovascular intervention in patients with diabetic foot ulcers. Adv Wound Care (New Rochelle). 2018;7:171–6.CrossRefGoogle Scholar
  13. 13.
    Yokoyama H, Matsushima M, Kawai K, Hirao K, Oishi M, Sugimoto H, et al. Low incidence of cardiovascular events in Japanese patients with type 2 diabetes in primary care settings: a prospective cohort study (JDDM 20). Diabet Med. 2011;28:1221–8.CrossRefPubMedGoogle Scholar
  14. 14.
    Faglia E, Dalla Paola L, Clerici G, Clerissi J, Graziani L, Fusaro M, et al. Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003. Eur J Vasc Endovasc Surg. 2005;29:620–7.CrossRefPubMedGoogle Scholar
  15. 15.
    Fujishima M, Kiyohara Y, Kato I, Ohmura T, Iwamoto H, Nakayama K, et al. Diabetes and cardiovascular disease in a prospective population survey in Japan: the Hisayama study. Diabetes. 1996;45(Suppl 3):S14–6.CrossRefPubMedGoogle Scholar
  16. 16.
    Nakagami T. Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin. Diabetologia. 2004;47:385–94.CrossRefPubMedGoogle Scholar
  17. 17.
    Kuwashiro T, Sugimori H, Ago T, Kuroda J, Kamouchi M, Kitazono T. The impact of predisposing factors on long-term outcome after stroke in diabetic patients: the Fukuoka Stroke Registry. Eur J Neurol. 2013;20:921–7.CrossRefPubMedGoogle Scholar
  18. 18.
    Kawasaki S, Misawa H, Tamura Y, Kondo Y, Satoh S, Hasegawa O, et al. Relationship between coronary artery disease and retinopathy in patients with type 2 diabetes mellitus. Intern Med. 2013;52:2483–7.CrossRefPubMedGoogle Scholar
  19. 19.
    Tsuboi S, Miyauchi K, Kasai T, Ogita M, Dohi T, Miyazaki T, et al. Impact of red blood cell distribution width on long-term mortality in diabetic patients after percutaneous coronary intervention. Circ J. 2013;77:456–61.CrossRefPubMedGoogle Scholar

Copyright information

© The Japan Diabetes Society 2018

Authors and Affiliations

  1. 1.Department of Diabetes Care MedicineOsaka University Graduate School of MedicineSuitaJapan
  2. 2.Cardiovascular CenterKansai Rosai HospitalAmagasakiJapan
  3. 3.Division of Metabolism and Biosystemic Science, Department of Internal MedicineAsahikawa Medical UniversityAsahikawaJapan

Personalised recommendations